New York State Common Retirement Fund lifted its stake in shares of Baxter International Inc. (NYSE:BAX – Free Report) by 7.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 476,248 shares of the medical instruments supplier’s stock after purchasing an additional 34,748 shares during the quarter. New York State Common Retirement Fund owned 0.09% of Baxter International worth $13,887,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of BAX. Fortitude Family Office LLC acquired a new stake in Baxter International during the third quarter worth about $38,000. LRI Investments LLC increased its stake in Baxter International by 60.8% in the third quarter. LRI Investments LLC now owns 1,560 shares of the medical instruments supplier’s stock valued at $59,000 after acquiring an additional 590 shares during the last quarter. Bruce G. Allen Investments LLC raised its position in Baxter International by 247.3% during the fourth quarter. Bruce G. Allen Investments LLC now owns 2,622 shares of the medical instruments supplier’s stock valued at $76,000 after purchasing an additional 1,867 shares in the last quarter. CKW Financial Group lifted its stake in Baxter International by 19.3% during the fourth quarter. CKW Financial Group now owns 2,625 shares of the medical instruments supplier’s stock worth $77,000 after purchasing an additional 425 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its holdings in shares of Baxter International by 23.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 2,519 shares of the medical instruments supplier’s stock valued at $96,000 after purchasing an additional 475 shares in the last quarter. Institutional investors own 90.19% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on BAX shares. Stifel Nicolaus lowered their price target on Baxter International from $46.00 to $38.00 and set a “buy” rating for the company in a report on Monday, November 11th. JPMorgan Chase & Co. dropped their price objective on shares of Baxter International from $38.00 to $36.00 and set a “neutral” rating for the company in a research note on Friday. StockNews.com cut shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Monday, November 11th. Barclays started coverage on Baxter International in a research note on Thursday. They issued an “overweight” rating and a $39.00 price target for the company. Finally, Citigroup lowered their target price on Baxter International from $37.00 to $35.00 and set a “neutral” rating for the company in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $38.80.
Baxter International Trading Up 1.3 %
NYSE:BAX opened at $33.87 on Monday. Baxter International Inc. has a 52 week low of $28.33 and a 52 week high of $44.01. The firm’s fifty day moving average is $30.65 and its 200-day moving average is $34.10. The firm has a market cap of $17.29 billion, a P/E ratio of -26.46, a P/E/G ratio of 10.62 and a beta of 0.61. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.09 and a current ratio of 1.43.
Baxter International (NYSE:BAX – Get Free Report) last issued its earnings results on Thursday, February 20th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. The business had revenue of $2.75 billion during the quarter, compared to the consensus estimate of $2.67 billion. Baxter International had a positive return on equity of 16.67% and a negative net margin of 5.05%. Equities analysts expect that Baxter International Inc. will post 2.48 earnings per share for the current year.
Baxter International Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Friday, February 28th will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date is Friday, February 28th. Baxter International’s payout ratio is -53.13%.
About Baxter International
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
Read More
- Five stocks we like better than Baxter International
- Breakout Stocks: What They Are and How to Identify Them
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- 3 Monster Growth Stocks to Buy Now
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Conference Calls and Individual Investors
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.